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educational status, killips class on admission, blood pressure on
admission, heart rate on admission (sinus rhythm), arrhythmias,
contraindication to thrombolytic therapy, STEMI / NON STEMI, Q
waves on admission, infarct location, pain to needle time, pain to
door time, door to needle time, ecg evidence of early reperfusion,
in hospital outcome edeath/further deterioration, functional
status at discharge, left ventricular ejection fraction at discharge,
mitral regurgitation at discharge.
Results: Total 204 patients were studied, out of which 198 patients
were thrombolysed. The results of which are as follows: out of 198
patients studied 164 (82.8%) were males and 34 (17.17%) were fe-
males. Most common age group of presentationwas 50-75 yrs. The
mean time of delayed presentation was found to be 4.5 hrs. The
delay to hospital was more in 50-75yrs age group (p value <0.05).
The delay was more in the diabetic patients as compared to the
patients without diabetes (p value<0.01). Patients with past his-
tory of angina, onset of symptoms in the early morning and late
night, low socioeconomic & low educational status was signifi-
cantly associated with delay of more than two hours in seeking
hospital care (p value< 0.05). The incidence of mortality, heart
failure, fatal arrhythmias, lower ejection fraction, acute kidney
injury, mitral regurgitation was more in patients presenting after
two hours.
Conclusion: The result of this study suggests that a large propor-
tion of patients with acute myocardial infarction continue to
exhibit delay in hospital presentation. The characteristic of many
of these individuals can be identified in advance for targeted
educational efforts.
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Background: Brain (B-type) natriuretic peptide is a neurohormone
synthesised predominantly by the ventricular myocardium.
Although initially BNP levels were used in the diagnosis of acute
heart failure, the circulating hormone has been shown to provide
independent prognostic value in patient with acute coronary
syndromes.
Method: This study comprised of prospective analysis of 50 pa-
tients of acute coronary syndromes (37 STEMI, 10 NSTEMI and 3
UA) admitted within 72hours of the event. The purpose of the
study was to study the effects of high admission BNP levels on
mortality and morbidity of patients at 30 days and at 6 months.
Results: The baseline level of B - type natriuretic peptide was
correlated with the risk of death, heart failure and death at 30 days
and at 6months. Among 50 patients, 21 patients whose admission
BNP levels were <¼80 pg/ml death occurred in 1 patients, CCF in 4,
NewMI in 7 and none in 9 patients occured at 30 days, and among
29 patients whose admission BNP levels were > 80 pg/ml, death
occured in 4 patients, CCF in 08 patients, New MI in 15 patients
and no complications was seen in 2 patients.(p value¼0.024).
At 6 months 21 patients whose admission BNP Levels were <¼
80 pg/ml death occured in 01 patients, CCF in 05 patients, New MI
in 08 patients and in 7 patients no complication was observed and
among 29 patients whose admission BNP levels were > 80 pg/ml,
death occured in 05 patients, CCF in 08 patients, New MI in 16
patients and none was observed in 0 patients.(p value¼0.007).
Conclusion: A single measurement of BNP levels obtained within
first few days after the onset of ischemic symptoms, provide
predictive information for use in risk stratification across spec-
trum of acute coronary syndromes.
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Background: Patients with coronary artery disease (CAD) poses
cardiologists, surgeons, and anesthetists with the dilemma of
deciding between the risk of increased blood loss when
continuing antiplatelet agents in the perioperative period, and the
risk of thromboembolic events if the drugs are stopped.
Aim: Analysis of the data, on the current practices of continuation
or discontinuation of anti-platelets in CAD patients undergoing
cardiac/non-cardiac surgery. In addition to observe adverse
events resulting from this practice.
Methods: Multi centric, retrospective, observational study con-
ducted in three tertiary care centers of India. A minimum 1537 pa-
tients with CAD undergoing surgeries will be included in the study.
ThePrimaryoutcomeof thestudy isperi-operative thromboembolic
events - stroke, pulmonary embolism, deep vein thrombosis and
acute coronary syndromes and the secondary outcome is Peri-
operativebleeding.Bleedingwasclassifiedasmajor (Type2 to5) and
minor (Type 0 and 1) as per the BARC definition of bleeding.
Results: In this ongoing study 513 patients have been enrolled.
The average age of the patients was 62 yr out of these 85.4% were
male. 414 (80.7 %) of patient underwent cardiac surgery and 99
(19.3%) patient underwent noncardiac surgery.
Of the patient who underwent cardiac surgery 352 (85 %) dis-
continued the anti platelet therapy while 40 (40.4 %) underwent
non cardiac surgery after discontinuing antiplatelets.
In cardiac surgery patient population , major bleeding occurred
in 6.0% in discontinuation group vs 3.2 % of patients in continu-
ation group (p ¼ 0.302). In non cardiac surgery population, major
bleeding were nil in both continuation and discontinuation group.
Conclusion: Antiplatelet was discontinued more often in patients
who underwent cardiac group. There was no significance in the
bleeding. Thrombotic events were not influenced by discontinu-
ation of antiplatelets.
Impact of atropine and aminophylline on
atrioventricular block after acute inferior wall
myocardial infarction
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Background: Intravenous (IV) aminophylline has been anecdotally
shown to improve conduction in atrio-ventricular (AV) block after
acute myocardial infarction (AMI).Present study tried to see the
efficacy of aminophylline in patients (pts.) who did not respond
with atropine.
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